APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment

MLA

Simon, Sjödin, et al. “APLP1 as a Cerebrospinal Fluid Biomarker for γ-Secretase Modulator Treatment.” Alzheimer’s Researchtherapy, vol. 7, no. 1, Aug. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c4de836027e10edd6163ab1b3ba99596&authtype=sso&custid=ns315887.

APA

Simon, S., Kerstin K A, A., Marc, M., Henrik, Z., Herman, B., Kaj, B., & Erik, P. (2015). APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment. Alzheimer’s Researchtherapy, 7(1).

Chicago

Simon, Sjödin, Andersson Kerstin K A, Mercken Marc, Zetterberg Henrik, Borghys Herman, Blennow Kaj, and Portelius Erik. 2015. “APLP1 as a Cerebrospinal Fluid Biomarker for γ-Secretase Modulator Treatment.” Alzheimer’s Researchtherapy 7 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c4de836027e10edd6163ab1b3ba99596&authtype=sso&custid=ns315887.